Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Dow
Fuji
Farmers Insurance
UBS
Moodys
US Department of Justice
Accenture
Daiichi Sankyo

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060188

« Back to Dashboard

NDA 060188 describes COR-OTICIN, which is a drug marketed by Akorn and is included in one NDA. Additional details are available on the COR-OTICIN profile page.

The generic ingredient in COR-OTICIN is hydrocortisone acetate; neomycin sulfate. There are sixty-four drug master file entries for this compound. Additional details are available on the hydrocortisone acetate; neomycin sulfate profile page.
Summary for 060188
Tradename:COR-OTICIN
Applicant:Akorn
Ingredient:hydrocortisone acetate; neomycin sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION/DROPS;OPHTHALMICStrength1.5%;EQ 3.5MG BASE/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fuji
Accenture
Queensland Health
Daiichi Sankyo
Mallinckrodt
Express Scripts
Dow
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.